These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23503445)

  • 1. A pilot study investigating tumor necrosis factor-α as a potential intervening variable of atypical antipsychotic-associated metabolic syndrome in bipolar disorder.
    Prossin AR; Zalcman SS; Evans SJ; McInnis MG; Ellingrod VL
    Ther Drug Monit; 2013 Apr; 35(2):194-202. PubMed ID: 23503445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics related metabolic syndrome in bipolar patients.
    Yumru M; Savas HA; Kurt E; Kaya MC; Selek S; Savas E; Oral ET; Atagun I
    J Affect Disord; 2007 Mar; 98(3):247-52. PubMed ID: 16970993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review and Meta-Analysis of Metabolic Syndrome Prevalence in Chinese Inpatients with Bipolar Disorder.
    Tao H; Shen D; Zhou Y; Sun F; Li G; Jin W
    Horm Metab Res; 2022 Sep; 54(9):587-592. PubMed ID: 35738391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.
    Ellingrod VL; Taylor SF; Dalack G; Grove TB; Bly MJ; Brook RD; Zöllner SK; Pop-Busui R
    J Clin Psychopharmacol; 2012 Apr; 32(2):261-5. PubMed ID: 22370993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
    Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
    World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders.
    Abdel Aziz K; Mohd Ahmed H; Stip E; Aly El-Gabry D
    Int Clin Psychopharmacol; 2024 Jul; 39(4):257-266. PubMed ID: 38381917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of metabolic syndrome in patients with bipolar disorder compared to a selected control group-a Northern Netherlands LifeLines population cohort study.
    Schuster MP; Borkent J; Chrispijn M; Ioannou M; Doornbos B; Burger H; Haarman BCM
    J Affect Disord; 2021 Dec; 295():1161-1168. PubMed ID: 34706429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study.
    Salvi V; D'Ambrosio V; Bogetto F; Maina G
    J Affect Disord; 2012 Feb; 136(3):599-603. PubMed ID: 22119084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and bipolar disorder: what should psychiatrists know?
    de Almeida KM; Moreira CL; Lafer B
    CNS Neurosci Ther; 2012 Feb; 18(2):160-6. PubMed ID: 22070636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
    Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
    J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia.
    Flowers SA; Baxter NT; Ward KM; Kraal AZ; McInnis MG; Schmidt TM; Ellingrod VL
    Pharmacotherapy; 2019 Feb; 39(2):161-170. PubMed ID: 30620405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of atypical antipsychotics-induced metabolic syndrome associated with MIF CATT >5/6 among females with chronic schizophrenia.
    Chen X; Huang H; Pu Z; Shi Y; Wang L; Yao S; Cui D
    Schizophr Res; 2024 Aug; 270():94-101. PubMed ID: 38889656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort.
    Flowers SA; Evans SJ; Ward KM; McInnis MG; Ellingrod VL
    Pharmacotherapy; 2017 Mar; 37(3):261-267. PubMed ID: 28035686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of metabolic syndrome as a mediator in the relationship between CCL11 levels and the presence of a mood episode with mixed features in young adults with bipolar disorder.
    Bender LV; Wirowski N; Lobato AS; Jansen K; Cardoso TA; Mondin TC; Oses JP; Kapczinski F; Souza LDM; Silva RAD; Pedrotti Moreira F
    J Psychiatr Res; 2024 Jul; 175():343-349. PubMed ID: 38761516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total gray matter volume is reduced in individuals with bipolar disorder currently treated with atypical antipsychotics.
    Birner A; Bengesser SA; Seiler S; Dalkner N; Queissner R; Platzer M; Fellendorf FT; Hamm C; Maget A; Pilz R; Lenger M; Reininghaus B; Pirpamer L; Ropele S; Hinteregger N; Magyar M; Deutschmann H; Enzinger C; Kapfhammer HP; Reininghaus EZ
    J Affect Disord; 2020 Jan; 260():722-727. PubMed ID: 31563071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
    Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.